➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: May 12, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 212306

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

NDA 212306 describes XPOVIO, which is a drug marketed by Karyopharm Theraps and is included in one NDA. There are five patents protecting this drug. Additional details are available on the XPOVIO profile page.

The generic ingredient in XPOVIO is selinexor. Additional details are available on the selinexor profile page.
Summary for 212306
Applicant:Karyopharm Theraps
DrugPatentWatch® Estimated Generic Entry Opportunity Date for 212306
Generic Entry Date for 212306*:
Constraining patent/regulatory exclusivity:

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength20MG
Approval Date:Jul 3, 2019TE:RLD:Yes
Regulatory Exclusivity Expiration:Jul 3, 2024
Regulatory Exclusivity Use:
Regulatory Exclusivity Expiration:Jul 3, 2026
Regulatory Exclusivity Use:
Regulatory Exclusivity Expiration:Jun 22, 2023
Regulatory Exclusivity Use:

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.